Farmacoriflessioni
Motivazioni di interesse per la fitoterapia
REASONS OF INTEREST FOR PHYTOTHERAPY
VITALIA MURGIA
Pediatra di famiglia, Mogliano Veneto (Treviso); International Academy of Phytotherapy
Marzo 2006 - pagg. 174 -180
Abstract
The use of herbal medicines, usually marketed as dietary (food, nutritional) supplements, is rapidly increasing all over the word. Such remedies are often perceived as being ‘natural and therefore free of risks’. There are numerous studies on the effectiveness of herbal medicine, but there is also some concern with the product quality due to limited regulation of dietary supplements and a certain lack of knowledge about their interaction with other drugs. This article is an attempt to review the use of herbal medicine products and to discuss some of the implications arising from it. Its aim is to alert healthcare professionals to the fact that herbal medicine products are not entirely free of risks.
Classificazione MeSH
Bibliografia
1. Gardiner P, Kemper KJ. Rimedi erboristici
in medicina dell’età pediatrica e dell’adolescenza.
Pediatrics in Review Vol.10, No. 3
giugno 2000.
2. AIFA Ministero della Salute. Il corretto uso delle erbe medicinali. Bollettino N.4 di Informazione sui farmaci 2005.
3. WHO monographs Selected medicinal plants Vol.1 , Vol. II World Health Organization Geneva (Edizione italiana a cura della SIFIT, Monografie di Piante Medicinali, volume I-II).
4. ESCOP (European Scientific Cooperative on Phytotherapy), Monographs,The Scientific Foundation for Herbal Medicinal products. 2° ed, 2003.
5. European Bulletin of Drug Research. Vol. 10, suppl. N°1, 2002.
6. Capasso F, Grandolini G. Fitofarmacia. Impiego razionale delle droghe vegetali. Springer 2003.
7. Ramsay HM, Goddard W, Gill S, Moss C. Herbal creams used for atopic eczema in Birmingham, UK illegally contain potent cor ticosteroids. Arch Dis Child 2003; 88:1056-7.
8. Ekahan, et al. Patient Education and Counselling 2004;53:5 e I.
9. Super EA. Cranberry use among pediatric nephrology patients. Ambul Pediatr 2005;(4):249-52.
10. Awang DVC. Maternal use of ginseng and neonatal androgenization. J Am Med Assoc 1991;266:363.
11. Conti ME, Botre F. Honeybees and their products as potential bioindicators of heavy metals contamination. Environ Monit Assess 2001 Jul;69(3):267-82.
12. Nortier JL, Vanherweghem JL, et al. Invasive urothelial carcinoma after exposure to Chinese herbal medicine containing aristolochic acid may occur without severe renal failure. Nephrol Dial Transplant 2003;18 (2):426-8.
13. Nortier JL, Vanherweghem JL, et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 2000;342(23):1686-92.
14. Vanherweghem JL, Depierreux M, Tielemans C, et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet. 1993;341(8842): 387-91.
15. Monti L. Prodotti medicinali vegetali: il problema della bioequivalenza. Piante Medicinali‚ 2003, Vol. 2, n° 2.
16. AIFA (Agenzia Italiana Del Farmaco), FarmacoVigilanza News 08/07/2005 (livello2).
2. AIFA Ministero della Salute. Il corretto uso delle erbe medicinali. Bollettino N.4 di Informazione sui farmaci 2005.
3. WHO monographs Selected medicinal plants Vol.1 , Vol. II World Health Organization Geneva (Edizione italiana a cura della SIFIT, Monografie di Piante Medicinali, volume I-II).
4. ESCOP (European Scientific Cooperative on Phytotherapy), Monographs,The Scientific Foundation for Herbal Medicinal products. 2° ed, 2003.
5. European Bulletin of Drug Research. Vol. 10, suppl. N°1, 2002.
6. Capasso F, Grandolini G. Fitofarmacia. Impiego razionale delle droghe vegetali. Springer 2003.
7. Ramsay HM, Goddard W, Gill S, Moss C. Herbal creams used for atopic eczema in Birmingham, UK illegally contain potent cor ticosteroids. Arch Dis Child 2003; 88:1056-7.
8. Ekahan, et al. Patient Education and Counselling 2004;53:5 e I.
9. Super EA. Cranberry use among pediatric nephrology patients. Ambul Pediatr 2005;(4):249-52.
10. Awang DVC. Maternal use of ginseng and neonatal androgenization. J Am Med Assoc 1991;266:363.
11. Conti ME, Botre F. Honeybees and their products as potential bioindicators of heavy metals contamination. Environ Monit Assess 2001 Jul;69(3):267-82.
12. Nortier JL, Vanherweghem JL, et al. Invasive urothelial carcinoma after exposure to Chinese herbal medicine containing aristolochic acid may occur without severe renal failure. Nephrol Dial Transplant 2003;18 (2):426-8.
13. Nortier JL, Vanherweghem JL, et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 2000;342(23):1686-92.
14. Vanherweghem JL, Depierreux M, Tielemans C, et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet. 1993;341(8842): 387-91.
15. Monti L. Prodotti medicinali vegetali: il problema della bioequivalenza. Piante Medicinali‚ 2003, Vol. 2, n° 2.
16. AIFA (Agenzia Italiana Del Farmaco), FarmacoVigilanza News 08/07/2005 (livello2).